Related Experiment Video
Updated: Apr 27, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A
Stéphanie Chasseigneaux, Christine Clamagirand, Léa Huguet
1INSERM UMR 894, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France. bernadette.allinquant@inserm.fr.
Background:
The neuronal cytoplasmic localization of SET, an inhibitor of the phosphatase 2A (PP2A), results in tau hyperphosphorylation in the brains of Alzheimer patients through mechanisms that are still not well defined.
Results:
We used primary neurons and mouse brain slices to show that SET is translocated to the cytoplasm in a manner independent of both its cleavage and over-expression. The localization of SET in the cytoplasm, either by the translocation of endogenous SET or by internalization of the recombinant full-length SET protein, induced tau hyperphosphorylation. Cytoplasmic recombinant full-length SET in mouse brain slices induced a decrease of PP2A activity through a decrease of methylated PP2A levels. The levels of methylated PP2A were negatively correlated with tau hyperphosphorylation at Ser-202 but not with the abnormal phosphorylation of tau at Ser-422.
Conclusions:
The presence of full-length SET in the neuronal cytoplasm is sufficient to impair PP2A methylation and activity, leading to tau hyperphosphorylation. In addition, our data suggest that tau hyperphosphorylation is regulated by different mechanisms at distinct sites. The translocation of SET to the neuronal cytoplasm, the low activity of PP2A, and tau hyperphosphorylation are associated in the brains of Alzheimer patients. Our data show a link between the translocation of SET in the cytoplasm and the decrease of methylated PP2A levels leading to a decrease of PP2A activity and tau hyperphosphorylation. This chain of events may contribute to the pathogenesis of Alzheimer disease.
Insights
SET protein in neuronal cytoplasm causes tau hyperphosphorylation, a key Alzheimer's disease event. This cytoplasmic SET impairs phosphatase 2A (PP2A) activity, linking it to Alzheimer's pathogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- SET, an inhibitor of phosphatase 2A (PP2A), is found in the neuronal cytoplasm in Alzheimer's disease (AD) brains.
- Its cytoplasmic localization is linked to tau hyperphosphorylation, a hallmark of AD, but the underlying mechanisms remain unclear.
Purpose of the Study:
- To elucidate the role of SET's neuronal cytoplasmic localization in tau hyperphosphorylation.
- To investigate the impact of cytoplasmic SET on PP2A activity and methylation.
- To establish the link between SET translocation, PP2A dysfunction, and AD pathogenesis.
Main Methods:
- Experiments using primary neurons and mouse brain slices.
- Investigating SET translocation, cleavage, and overexpression.
- Assessing tau phosphorylation levels (Ser-202, Ser-422) and PP2A activity/methylation.
Main Results:
- SET translocation to the cytoplasm, independent of cleavage or overexpression, induces tau hyperphosphorylation.
- Cytoplasmic SET reduces PP2A activity by decreasing methylated PP2A levels.
- Decreased methylated PP2A levels correlate with tau hyperphosphorylation at Ser-202.
Conclusions:
- Neuronal cytoplasmic localization of full-length SET is sufficient to impair PP2A methylation and activity, causing tau hyperphosphorylation.
- This SET-induced cascade, involving decreased PP2A activity and tau hyperphosphorylation, contributes to Alzheimer's disease pathogenesis.
- Distinct mechanisms may regulate tau phosphorylation at different sites.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
PI3K/mTOR/AKT Signaling Pathway
Microtubule Associated Proteins (MAPs)
Microtubule Instability
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

